
Cell MedX Corp.
Aktie · US15115X1072 (OTC)
Kein Kurs
n/a
Firmenprofil zu Cell MedX Corp. Aktie
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.
Unternehmensdaten
Name Cell MedX Corp.
Firma Cell MedX Corp.
Website
https://www.cellmedx.com
Heimatbörse
UTC
ISIN US15115X1072
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Devices
CEO David M. Jeffs
Marktkapitalisierung 126 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter -
Adresse 123 West Nye Ln, 89706 Carson City
IPO Datum 2013-08-29
Ticker Symbole
| Name | Symbol |
|---|---|
| Over The Counter | CMXC |
Weitere Aktien
Investoren, die Cell MedX Corp. halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.



